SIPAI HEALTH (00314) spent 290,100 Hong Kong dollars to repurchase 200,000 shares on May 27th.
Sino Biopharmaceutical (00314) announced on May 27, 2026, that the company repurchased 200,000 shares at a cost of HK$290,100.
SIPAI HEALTH (00314) announced on May 27, 2026 that the company has allocated 290,100 Hong Kong dollars to repurchase 200,000 shares.
Related Articles
Suzhou Highfine Biotech (301393.SZ): Employee strategic placement management plan intends to reduce holdings of company shares by no more than 0.5%
JP Morgan increased its holdings in CMOC Group Limited (03993) by approximately 12.36 million shares, with an average price of approximately HK$18.24 per share.
COMBA (02342) spent around 655,100 Hong Kong dollars to repurchase 500,000 shares on May 27th.
Suzhou Highfine Biotech (301393.SZ): Employee strategic placement management plan intends to reduce holdings of company shares by no more than 0.5%
JP Morgan increased its holdings in CMOC Group Limited (03993) by approximately 12.36 million shares, with an average price of approximately HK$18.24 per share.
COMBA (02342) spent around 655,100 Hong Kong dollars to repurchase 500,000 shares on May 27th.
